Bazedoxifene Acetate; Estrogens, Conjugated Patent Expiration
Bazedoxifene Acetate; Estrogens, Conjugated is used for management of menopausal symptoms and prevention of osteoporosis. It was first introduced by Wyeth Pharmaceuticals Llc
Bazedoxifene Acetate; Estrogens, Conjugated Patents
Given below is the list of patents protecting Bazedoxifene Acetate; Estrogens, Conjugated, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Duavee | US5998402 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Apr 04, 2019
(Expired) | Wyeth Pharms |
| Duavee | US6479535 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
May 06, 2024
(Expired) | Wyeth Pharms |
| Duavee | US7138392 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Apr 04, 2017
(Expired) | Wyeth Pharms |
| Duavee | US7683051 | Crystalline polymorph of bazedoxifene acetate | Mar 10, 2027 | Wyeth Pharms |
| Duavee | US8815934 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations |
May 06, 2019
(Expired) | Wyeth Pharms |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳